State of the Science

Topic: The Future of OSA Treatment

Overview: First line treatment for OSA remains CPAP but there is increasing interest in pharmacotherapy and other procedures/devices for sleep apnea. We will explore the existing data on CPAP, and the use of medications for sleep apnea as either second line therapy or adjunctive therapy. We will further review other advances in OSA therapeutics as well as management of diagnostic and serial testing.

Monday, September 15, 2025
9:30am – 11:00am Eastern Time (90 minutes)
Webinar held via zoom

Speakers

Atul Malhotra, MD, FAASM (Chair)
Chief of Pulmonary, Critical Care, and Sleep Medicine,
University of California, San Diego School of Medicine

Reena Mehra MD, MS, FCCP FAASM FAHA ATSF
A. Bruce Montgomery, MD, American Lung Association
Endowed Chair in Pulmonary and Critical Care Medicine
Division Head, Pulmonary, Critical Care and Sleep Medicine
Associate Editor, American Journal of Respiratory and Critical Care Medicine
Professor of Medicine, University of Washington

Anne Marie Morse, DO, FAASM
Director of Child Neurology and Pediatric Sleep Medicine,
Janet Weis Children’s Hospital, Geisinger Health System

Neomi Shah, MD, MPH, MS
Professor of Medicine, Associate Dean, Faculty Career Advancement
System Vice Chair of Medicine for Faculty Affairs
Director of Clinical Strategy and Oversight, Respiratory Institute
Division of Pulmonary, Critical Care, and Sleep Medicine
Samuel Bronfman Department of Medicine, Icahn School of Medicine at Mount Sinai

Learning Objectives

  1. To understand sleep apnea epidemiology and current/future diagnostic approaches
  2. To review recent data regarding CPAP from meta-analyses and clinical trials
  3. To appreciate the surmount OSA and mariposa studies
  4. To review the data on hypoglossal nerve stimulation
  5. To consider future directions in OSA therapy

Complimentary, Advanced Registration Required

This educational webinar is hosted by the SRS Foundation.

A special thank you to our corporate partners for supporting this program – Lilly, Inspire Medical Systems, Nox Medical, Fisher & Paykel Healthcare, Wesper, Resmed, SleepImage, and Natus Medical.